Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool

The current screening test for prostate cancer (PCa) has the weak point of a high false-negative rate and a low true positive rate. There is an extreme need for a new and accurate testing system. Circulating Tumor Cells (CTCs) as the main liquid biopsy components provide excellent biomarkers for ear...

Full description

Bibliographic Details
Main Authors: Fatemeh Khatami, Mandana Hasanzad
Format: Article
Language:English
Published: Urology Research Center 2020-08-01
Series:Translational Research in Urology
Subjects:
Online Access:https://www.transresurology.com/article_120191.html
_version_ 1819005493294661632
author Fatemeh Khatami
Mandana Hasanzad
author_facet Fatemeh Khatami
Mandana Hasanzad
author_sort Fatemeh Khatami
collection DOAJ
description The current screening test for prostate cancer (PCa) has the weak point of a high false-negative rate and a low true positive rate. There is an extreme need for a new and accurate testing system. Circulating Tumor Cells (CTCs) as the main liquid biopsy components provide excellent biomarkers for early diagnosis of PCa, prognosis, recurrence risk, and treatment efficacy. These tumor cells can get the release of tumor and freely circulate in the patient’s body fluids and easily are traceable to answer the presence of the tumor more than its stage. The new gifted ISET®-CTC Test is a simple blood test with high sensitivity and specificity for the detection of CTC in PCa. As a novel idea, it is a challengeable point nowadays that it needs further studies.
first_indexed 2024-12-20T23:53:40Z
format Article
id doaj.art-e4a7a1e2bb81432fba647a281a2133e2
institution Directory Open Access Journal
issn 2717-042X
language English
last_indexed 2024-12-20T23:53:40Z
publishDate 2020-08-01
publisher Urology Research Center
record_format Article
series Translational Research in Urology
spelling doaj.art-e4a7a1e2bb81432fba647a281a2133e22022-12-21T19:22:47ZengUrology Research CenterTranslational Research in Urology2717-042X2020-08-0123939510.22034/TRU.2020.260779.1055Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic ToolFatemeh Khatami 0Mandana Hasanzad1Urology Research Center, Tehran University of Medical Sciences, Tehran, IranMedical Genomics Research Center, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, IranThe current screening test for prostate cancer (PCa) has the weak point of a high false-negative rate and a low true positive rate. There is an extreme need for a new and accurate testing system. Circulating Tumor Cells (CTCs) as the main liquid biopsy components provide excellent biomarkers for early diagnosis of PCa, prognosis, recurrence risk, and treatment efficacy. These tumor cells can get the release of tumor and freely circulate in the patient’s body fluids and easily are traceable to answer the presence of the tumor more than its stage. The new gifted ISET®-CTC Test is a simple blood test with high sensitivity and specificity for the detection of CTC in PCa. As a novel idea, it is a challengeable point nowadays that it needs further studies.https://www.transresurology.com/article_120191.htmlcirculating tumor cellsprostate cancerbenign prostatic hyperplasia
spellingShingle Fatemeh Khatami
Mandana Hasanzad
Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
Translational Research in Urology
circulating tumor cells
prostate cancer
benign prostatic hyperplasia
title Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
title_full Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
title_fullStr Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
title_full_unstemmed Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
title_short Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
title_sort circulating tumor cells as a novel prostate cancer diagnostic tool
topic circulating tumor cells
prostate cancer
benign prostatic hyperplasia
url https://www.transresurology.com/article_120191.html
work_keys_str_mv AT fatemehkhatami circulatingtumorcellsasanovelprostatecancerdiagnostictool
AT mandanahasanzad circulatingtumorcellsasanovelprostatecancerdiagnostictool